The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/40385
StudyName: Eligibility Indolent Non-follicular NCT01929265
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 17.04.2020
License: Creative Commons BY 4.0

----

Description: 
A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01929265
